Last reviewed · How we verify
Placebo( for misoprostol)
This is a placebo control with no active pharmacological mechanism.
This is a placebo control with no active pharmacological mechanism. Used for Control arm in Phase 3 clinical trial comparing misoprostol efficacy.
At a glance
| Generic name | Placebo( for misoprostol) |
|---|---|
| Sponsor | Ain Shams University |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
A placebo is an inert substance used as a control in clinical trials to establish the true efficacy of the active comparator (misoprostol in this case). It produces no direct pharmacological effect and serves to account for placebo response and natural disease progression in Phase 3 trial design.
Approved indications
- Control arm in Phase 3 clinical trial comparing misoprostol efficacy
Common side effects
Key clinical trials
- Effect of Misoprostol on Fluid Deficit Volume in Hysteroscopic Myomectomy (PHASE4)
- Sublingual Misoprostol Versus No Cervical Priming Before Hysteroscopic Resection of Symptomatic Uterine Niches (NA)
- Letrozole Plus Misoprostol Versus Misoprostol Alone for Treating Women With Missed Miscarriage (PHASE4)
- Letrozole Versus Mifepristone and Misoprostol in Silent Miscarriage (NA)
- Significance of Misoprostol-induced Cervical Ripening Prior to Hysteroscopy (NA)
- Termination Of Anembryonic Pregnancy (PHASE2)
- Misoprostol Versus Oxytocin for Induction of Labour in Parturients With Spontaneous Rupture of Fetal Membranes at Term (NA)
- Outpatient Cervical Ripening With Orally Administered Misoprostol in Diabetics (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo( for misoprostol) CI brief — competitive landscape report
- Placebo( for misoprostol) updates RSS · CI watch RSS
- Ain Shams University portfolio CI